Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2009 - 2026)

Johnson & Johnson has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $2.4 billion for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $2.4 billion, changed 0.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 billion (changed 0.06% YoY), and the FY2025 annual result was $2.4 billion, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $2.4 billion for Q1 2026 at Johnson & Johnson, roughly flat from $2.4 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.6 billion in Q1 2022 to a low of $2.4 billion in Q2 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $2.5 billion (2023), against an average of $2.5 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) slipped 7.57% in 2024 and climbed 0.06% in 2026, its largest moves.
• Johnson & Johnson's Shares Outstanding (Weighted Average) stood at $2.6 billion in 2022, then fell by 3.59% to $2.5 billion in 2023, then decreased by 4.98% to $2.4 billion in 2024, then rose by 0.0% to $2.4 billion in 2025, then rose by 0.05% to $2.4 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $2.4 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.